IP Library Granted Patent US 12,137,713
Granted Patent B2
US 12,137,713 · App. 17/684,278 · Granted Nov 12, 2024

Devices and methods for the preparation of a nutritional formula

Inventors: Eric First (Morristown, NJ); David Brown (Brookline, MA); Albert Archie Stone (Fuquay-Varina, NC)
Assignee: Alcresta Therapeutics, Inc.
A23L29/06A23L33/12A61J15/0026A61J15/0076A61J15/0092A61K38/465A61K38/47A61K38/48C12N9/20C12N9/2411C12N9/50C12Y301/01003C12Y302/01001C12Y304/00A23L33/40A61J3/002A61K9/0029A61M5/1409A61M5/142A61M5/16827
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,137,713
App. No.
17/684,278
Granted
Nov 12, 2024
Kind
B2
Abstract

Exemplary embodiments of the disclosure may be drawn to a device having an inlet and a chamber. Immobilized lipase, immobilized protease, and immobilized amylase may be contained within the chamber. The device may also include an outlet, wherein a flow path extends from the inlet, through the chamber, and to the outlet.

Claims (33)

1. A device comprising:

an inlet;

a chamber;

immobilized lipase contained within the chamber;

immobilized protease contained within the chamber;

immobilized amylase contained within the chamber; and

an outlet, wherein a flow path extends from the inlet, through the chamber, and to the outlet, so that a nutritional formula flowing through the device is exposed to the lipase, the protease, and the amylase, wherein the resulting hydrolyzed nutritional formula, upon flowing from the outlet, does not contain the immobilized lipase, the immobilized protease, or the immobilized amylase.

2. The device of claim 1 , wherein the chamber includes one or more sections.

3. The device of claim 2 , wherein the lipase, the protease, and the amylase are contained within one section of the chamber.

4. The device of claim 2 , wherein the chamber includes a first section, a second section, and a third section.

5. The device of claim 4 , wherein the lipase is contained within the first section, the protease is contained within the second section, and the amylase is contained within the third section.

6. The device of claim 2 , wherein the chamber includes a first section and a second section.

7. The device of claim 6 , wherein the first section contains at least two of the amylase, the protease, or the lipase.

8. The device of claim 2 , further comprising a supplement, wherein the chamber includes a first section and a second section, and the first section contains the supplement.

9. The device of claim 8 , wherein the supplement includes at least one of a vitamin, a mineral, a nutrient, a medicament, a probiotic, or a prebiotic.

10. The device of claim 2 , wherein at least one of the chamber or the one or more sections is removably coupled to the device.

11. The device of claim 1 , further comprising a first connector fluidly connected to the inlet and a second connector fluidly connected to the outlet, wherein the first connector and the second connector are dimensioned to connect to a feeding tube.

12. The device of claim 1 , wherein at least one of the lipase, the protease, or the amylase is immobilized to a plurality of particles contained within the chamber.

13. A device comprising:

an inlet;

a chamber;

lipase contained within the chamber;

protease contained within the chamber;

amylase contained within the chamber; and

an outlet, wherein a flow path extends from the inlet, through the chamber, and to the outlet so that a nutritional formula flowing through the device is exposed to the lipase, the protease, and the amylase;

wherein the lipase, the protease, and the amylase are immobilized within the chamber to a solid structure.

14. The device of claim 13 , wherein the solid structure includes a plurality of particles contained within the chamber.

15. The device of claim 13 , further comprising at least one of a vitamin, a mineral, a nutrient, a medicament, a probiotic, or a prebiotic.

16. The device of claim 13 , wherein the chamber includes one or more sections, and the lipase, the protease, and the amylase are contained within the one or more sections.

17. The device of claim 16 , wherein the lipase, the protease, and the amylase are each contained in separate sections of the one or more sections.

18. The device of claim 16 , wherein at least one of the chamber or the one or more sections is removably coupled to the device.

19. The device of claim 13 , wherein the lipase, the protease, and the amylase are each immobilized within the chamber to one or more solid structures.

20. The device of claim 13 , further comprising a first connector fluidly connected to the inlet and a second connector fluidly connected to the outlet, wherein the first connector and the second connector are dimensioned to connect to a feeding tube.

Assignments (2)
SECURITY INTEREST Recorded Mar 12, 2024
From: ALCRESTA THERAPEUTICS, INC.
To: TWIN BROOK CAPITAL PARTNERS, LLC, AS AGENT
Reel/Frame 066742/0319 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2022
From: FIRST, ERIC; BROWN, DAVID; STONE, ALBERT ARCHIE
To: ALCRESTA THERAPEUTICS, INC.
Reel/Frame 059152/0087 →
Continuity (4)
Continuation 16123712 · Sep 6, 2018
Provisional Application 62643394 · Mar 15, 2018
Provisional Application 62556700 · Sep 11, 2017
Related Publication 20220264926A1 · Aug 25, 2022